AzTrials
AzTrials

Weakness, MuscleAFMPRNCT03987997

Bed Rest and Muscle Strength in ICU: Interest in the Early Association of NEMS With Cyclo-ergometer Mobilization

A study testing Early association of electrical muscle stimulation with cyclo-ergometer in people with Weakness, Muscle, run by Direction Centrale du Service de Santé des Armées at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Muscles atrophy and weakness are common in intensive care units, their origin is multifactorial. Passive then active mobilization with cyclo-ergometer have shown to improve functional abilities and limit muscle weakness among intensive care unit patients. Read more about this study

Who is it for?
Ages 18 to 75 years
Conditions the study is for
Weakness, Muscle
What is being tested?
Early association of electrical muscle stimulation with cyclo-ergometer
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
55 participants
Where
1 siteFrance
Study dates
9 Aug 2018to 26 Dec 2021
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Patient affiliated to a social security scheme
  • Patient hospitalized in intensive care unit for medical or surgical reasons, under assisted ventilation (invasive, non-invasive ventilation or oxygen-therapy at high speed via the Optiflow(r) system delivering a flow between 30 and 60 L.min and a FiO2 between 30 and 100%)
  • State of the patient deemed stable buy the doctor responsible for the care and allowing the action of the physiotherapist (acts on medical prescription)
  • Age more than 18 years old (major patient) and less than 75 years old
  • Duration of mechanical ventilation (invasive or not) less than or equal to 72 hours at the beginning of the inclusion
  • Predicable duration of stay greater than or equal to 3 days

Who cannot join

  • Impossibility to know the consent of the patient, his legal representative or the person of trust
  • Patient under safeguard of justice, tutorship or curatorship
  • Legionnaire not rectified
  • Cardiac stimulator or defibrillator
  • Cardiorespiratory state clinically not compatible withe early mobilization
  • Neurological problems: intracranial pressure > 20 mmHg, presence of ICU acquired neuropathy, pre-existing diagnosis of neuromuscular disease (MS, ALS...), acute stroke, epilepsy
Show all 15Show fewer
  • Orthopedic problems: even partial amputation of a lower limb, unstable fracture, suspicion of fracture, non-fixed spinal cord injury, use of a technique that does not allow to comply with postoperative surgical instructions (range of motion, discharge...), untreated deep vein thrombosis, traumatic sequelae to the origin of disabling manifest muscle weakness of a lower limb at admission
  • Dermatological problems: severe lesions or complex dressing in the lower limbs
  • Morphological criteria : size < 1.5m, BMI > 35
  • Confirmed psychiatric illness or severe agitation
  • Abdominal surgery without protection by compression belt (medical prescription), or too fragile (medical opinion)
  • Pregnant or lactating women (postpartum is not an exclusion criterion)
  • Patients over 75 years old
  • Hemiplegia / sequential hemiparesis
  • Impossibility to practice electrostimulation on at least one lower limb (manifest muscle weakness of a lower limb at admission (e. g. related to a traumatic sequelae)

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Hôpital d'intruction des armées Clermont-Tonnerre

    Brest, 29200

    Christophe GIACARDI, MD, +33 2 98 43 74 92, christophe.giacardi@intradef.gouv.fr

    Thibault BAUDIC, Intern, +33 683922914, thibaut.baudic@yahoo.fr

    Recruiting

Other trials in France

About this study

Official title: Bed Rest and Muscle Strength in Resuscitation Patients: Interest in the Early Association of NEMS With Cyclo-ergometer Mobilization

Muscles atrophy and weakness are common in intensive care units, their origin is multifactorial. Passive then active mobilization with cyclo-ergometer have shown to improve functional abilities and limit muscle weakness among intensive care unit patients. Electrical muscle stimulation should limit the atrophy and muscle weakness in intensive care unit associated with early mobilization.

This study aims to compare the association early cyclo-ergometer mobilization with electrical muscle stimulation versus cyclo-ergometer mobilization only to prevent muscle atrophy and weakness in intensive care unit.

Being tested
Early association of electrical muscle stimulation with cyclo-ergometer
Keywords
Intensive Care Units, Critical Illness, Rehabilitation, Muscle atrophy, Muscle weakness, Cyclo-ergometer, Electrical muscle stimulation
Medical subject headings
Muscle Weakness, Critical Illness, Muscular Atrophy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Early association of electrical muscle stimulation with cyclo-ergometerDevice

    Early electrical muscle stimulation in patients usually mobilized with cyclo-ergometer in ICU.

Study groups in NCT03987997
Study groupRoleWhat they receive
Association electrical muscle stimulation with cyclo-ergometerActive comparatorRandomized leg with receive electrical muscle stimulation of the quadriceps in addition to early mobilization of lower limbs with cyclo-ergometer.
Receives: Device: Early association of electrical muscle stimulation with cyclo-ergometer
Cyclo-ergometer onlyOtherThis control group correspond to the leg which don't receive electrical muscle stimulation (as usually supported)
Receives: Device: Early association of electrical muscle stimulation with cyclo-ergometer

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of muscle mass of quadriceps assessed with ultrasonography

    Muscle mass of quadriceps assessed by ultrasonography. The member who receives the cyclo-ergometer mobilization alone serves as a control for the member who receives the mobilization by cyclo-ergometer and electrical muscle stimulation

    Measured: at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

Secondary outcomes (4)
  1. Change of muscle strength of lower limb assessed by dynamometry

    Muscle strength of lower limb assessed by dynamometry. The member who receives the cyclo-ergometer mobilization alone serves as a control for the member who receives the mobilization by cyclo-ergometer and electrical muscle stimulation

    Measured: at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

  2. Change of pedalling symmetry right/left

    Assessed with the cyclo-ergometer associated pic torque

    Measured: at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

  3. Change of power variation of lower limb

    Power variation of lower limb assessed with cyclo-ergometer

    Measured: at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)

  4. Change of work variation of lower limb

    Work variation of lower limb assessed with cyclo-ergometer

    Measured: Every cyclo-ergometer session, 5 days on 7 (at least 6 months)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2019
  2. Study start9 Aug 2018
  3. Primary completion26 Nov 2021 (estimated)
  4. Study completion26 Dec 2021 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
Leg with electrical muscle stimulation and cycling versus leg with cycling only
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
55 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03987997
Sponsor's protocol ID
2016RC02
Other IDs
2018-A01330-55
Acronym
AFMPR
Status last verified
Jun 2019
First submitted
13 May 2019
Last updated
17 Jun 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Early association of electrical muscle stimulation with cyclo-ergometer in people with Weakness, Muscle, run by Direction Centrale du Service de Santé des Armées at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 15 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Jun 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of muscle mass of quadriceps assessed with ultrasonography (time frame: at day 0, then every 7 days (+/- 2 days) until ICU discharge (at least 6 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Jun 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in